How long was Zantac on the market?

Zantac, a popular drug used for treating chronic heartburn, was on the market from when it was first introduced in 1983, to when it was recalled from the market in 2020. Zantac’s main active ingredient, ranitidine, has been linked to an increased risk of cancer in patients taking Zantac. In addition, the cancer-causing chemical, NDMA, has been found to increase in Zantac as it ages, and possibly even as the drug is metabolized in the body.

For these reasons, the FDA requested manufacturers to withdraw all prescription and over-the-counter drugs containing ranitidine immediately. Additionally, a number of lawsuits have been brought against Zantac’s manufacturers alleging the companies knew about the dangers and neglected to alert the public or medical community.

If you’ve developed cancer after using the defective medication Zantac as a heartburn treatment regimen, you could be entitled to compensation. Call the mass tort attorneys at Gordon McKernan Injury Attorneys for a free legal consultation today.